NCT04490564View on ClinicalTrials.gov

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

UnknownOBSERVATIONAL
Enrollment

185

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

May 25, 2023

Study Completion Date

June 25, 2023

Conditions
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Interventions
DIAGNOSTIC_TEST

PD-L1 Kit

Clinical performance of PD-L1 kit in CTCs of peripheral blood and tumor tissue samples

Trial Locations (6)

11527

Sotiria Thoracic Diseases Hospital of Athens, Athens

11528

Aretaieio University Hospital of Athens, Athens

18547

Metropolital Hospital, Piraeus

68100

University General Hospital of Alexandroupoli, Alexandroupoli

124 62

University General Hospital of Athens Attikon, Athens

546 22

Bioclinic, Thessaloniki

Sponsors

Lead Sponsor

Pharmassist Ltd
All Listed Sponsors
collaborator

University of Athens

OTHER

lead

Pharmassist Ltd

INDUSTRY

NCT04490564 - Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma | Biotech Hunter | Biotech Hunter